Diagnostic Services

Octreotide Scan

The Octreotide Scan Facility offers specialized nuclear imaging to detect neuroendocrine tumors and assess their activity. By utilizing octreotide, a radiopharmaceutical tracer that binds to somatostatin receptors commonly found on these tumors, this non-invasive scan provides valuable information for diagnosis and treatment planning. Our experienced team leverages advanced imaging technology to ensure accurate results, facilitating targeted management strategies for patients with neuroendocrine disorders.